fda warning letters compounded semaglutide tirzepatide 2025 issued 25 to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Last month, the FDA issued

Diarrhea, gas, and constipation arent the most glamorous things to bring up at an appointment

Store at room temperature, in a dry place

By avoiding compounded medications, we ensure that you receive treatments with verified quality and safety, backed by thorough regulatory oversight

Some providers attempt to navigate this by prescribing Ozempic off-label for weight loss in patients with prediabetes or metabolic syndrome

The ACC notes that clinicians should pay attention to gastrointestinal side effects, drug interactions, nutrition, and the patients overall cardiovascular situation when using GLP 1 therapies in practice